Nektar Therapeutics
NKTR
#4842
Rank
A$2.71 B
Marketcap
A$96.88
Share price
-7.06%
Change (1 day)
384.02%
Change (1 year)

Nektar Therapeutics (NKTR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$0.30 Billion

According to Nektar Therapeutics 's latest financial reports the company's total liabilities are A$0.30 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.39 B-0.28%
2023-12-31A$0.39 B-22.45%
2022-12-31A$0.50 B-16.28%
2021-12-31A$0.60 B0.59%
2020-12-31A$0.60 B-26.54%
2019-12-31A$0.81 B33.03%
2018-12-31A$0.61 B13.86%
2017-12-31A$0.53 B-19.14%
2016-12-31A$0.66 B-1.29%
2015-12-31A$0.67 B36.44%
2014-12-31A$0.49 B-15.77%
2013-12-31A$0.58 B35.54%
2012-12-31A$0.43 B8.81%
2011-12-31A$0.39 B-5.95%
2010-12-31A$0.42 B-19.52%
2009-12-31A$0.52 B0.33%
2008-12-31A$0.52 B-10.12%
2007-12-31A$0.58 B-14.91%
2006-12-31A$0.68 B-5.54%
2005-12-31A$0.72 B102.6%
2004-12-31A$0.35 B-41.09%
2003-12-31A$0.60 B-14.21%
2002-12-31A$0.70 B-8.75%
2001-12-31A$0.77 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$166.60 B 54,309.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$163.72 B 53,370.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$114.01 B 37,133.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A$19.75 B 6,351.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$109.92 B 35,800.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$92.53 B 30,120.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
A$61.29 M-79.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A$0.84 B 175.63%๐Ÿ‡ฎ๐Ÿ‡ช Ireland